We are live on
!
Find out more
Sands Capital Management Portfolio holdings
AUM
$25.5B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
-16.18%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.17%
AUM
$28B
AUM Growth
-$7.34B
(-21%)
Cap. Flow
-$1.38B
Cap. Flow
% of AUM
-4.94%
Top 10 Holdings %
Top 10 Hldgs %
52.52%
Holding
75
New
7
Increased
21
Reduced
39
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$355M |
| 2 |
Atlassian
TEAM
|
+$155M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$149M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$142M |
| 5 |
Align Technology
ALGN
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$483M |
| 2 |
Meta Platforms (Facebook)
META
|
+$395M |
| 3 |
Booking.com
BKNG
|
+$234M |
| 4 |
Baidu
BIDU
|
+$195M |
| 5 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Consumer Discretionary | 23.4% |
| 3 | Healthcare | 21.77% |
| 4 | Communication Services | 15.3% |
| 5 | Financials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Sarepta Therapeutics
SRPT
$1.64B
| $338M | 1.21% |
3,094,767
+1,193,203
| +63% | +$149M |
|
27
Alphabet (Google) Class C
GOOG
$4.11T
| $334M | 1.19% |
6,451,360
-310,760
| -5% | -$16.6M |
|
|
28
Match Group
MTCH
$9.19B
| $330M | 1.18% |
+7,724,932
| New | +$355M |
|
29
Starbucks
SBUX
$119B
| $322M | 1.15% |
4,996,429
-212,344
| -4% | -$13.3M |
|
|
ATVI
30
DELISTED
Activision Blizzard
ATVI
| $283M | 1.01% |
6,073,842
-463,726
| -7% | -$27.8M |
|
31
Incyte
INCY
$25.8B
| $278M | 0.99% |
4,364,395
-161,589
| -4% | -$10.5M |
|
|
ABMD
32
DELISTED
Abiomed Inc
ABMD
| $277M | 0.99% |
852,360
+408,753
| +92% | +$142M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
| $269M | 0.96% |
2,766,636
-198,591
| -7% | -$23.5M |
|
|
LKFT
34
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $266M | 0.95% |
2,894,535
-104,804
| -3% | -$10.6M |
|
|
LOXO
35
DELISTED
Loxo Oncology, Inc
LOXO
| $241M | 0.86% |
1,722,467
-122,363
| -7% | -$18.6M |
|
36
Floor & Decor
FND
$6.03B
| $231M | 0.82% |
8,904,254
+2,173,981
| +32% | +$63.4M |
|
37
Las Vegas Sands
LVS
$31.4B
| $220M | 0.79% |
4,235,916
-161,302
| -4% | -$8.74M |
|
|
NBIS
38
Nebius Group N.V.
NBIS
$37.6B
| $138M | 0.49% |
5,044,831
+715,837
| +17% | +$21M |
|
39
TSMC
TSM
$1.94T
| $115M | 0.41% |
3,113,800
+323,851
| +12% | +$12.3M |
|
40
iShares MSCI India ETF
INDA
$6.81B
| $114M | 0.41% |
3,427,060
-428,456
| -11% | -$13.5M |
|
41
Trip.com Group
TCOM
$29B
| $96.1M | 0.34% |
3,550,797
+459,013
| +15% | +$14M |
|
42
Mercado Libre
MELI
$94.5B
| $91.6M | 0.33% |
312,754
+45,681
| +17% | +$14.8M |
|
|
43
Baidu
BIDU
$35.7B
| $78.3M | 0.28% |
493,786
-1,045,487
| -68% | -$195M |
|
44
MakeMyTrip
MMYT
$5.38B
| $65.6M | 0.23% |
2,695,114
+305,950
| +13% | +$7.35M |
|
45
Grupo Aeroportuario del Sureste
ASR
$8.16B
| $55.7M | 0.2% |
369,890
+42,438
| +13% | +$6.87M |
|
46
HDFC Bank
HDB
$123B
| $47.8M | 0.17% |
1,844,548
+297,924
| +19% | +$7.04M |
|
|
PLAN
47
DELISTED
Anaplan, Inc.
PLAN
| $42.5M | 0.15% |
+1,602,317
| New | +$39.6M |
|
48
Sea Limited
SE
$66.4B
| $35.9M | 0.13% |
3,171,815
+377,375
| +14% | +$4.72M |
|
|
ONC
49
BeOne Medicines Ltd
ONC
$33.9B
| $34.4M | 0.12% |
245,197
+151,354
| +161% | +$20.1M |
|
50
Zoetis
ZTS
$32.7B
| $23.2M | 0.08% |
270,867
+30,932
| +13% | +$2.79M |
|
Similar funds
KK
VAI
UIM
Sands Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Sands Capital Management held 75 positions worth $28B, down 21% from $35.4B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Sands Capital Management withdrew a net $1.38B in Q4 2018, closing 4 positions and reducing 39 holdings. Its most notable exit was Medidata Solutions, Inc., an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Sands Capital Management opened a new position in Match Group worth $330M.
- Sands Capital Management's largest Q4 2018 buy was Match Group: 7,724,932 shares worth $330M.
- Sands Capital Management added most to Atlassian in Q4 2018, an estimated $155M increase.
- Sands Capital Management's biggest Q4 2018 reduction was Charles Schwab, cutting an estimated $483M.
- Sands Capital Management fully exited Medidata Solutions, Inc. in Q4 2018, selling an estimated $157M.
- Sands Capital Management's ten largest holdings make up 53% of its $28B portfolio in Q4 2018.
- Sands Capital Management opened 7 new positions and closed 4 in Q4 2018.
- Sands Capital Management's portfolio value fell 21% quarter-over-quarter to $28B.
Based on Sands Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.